Hong Kong Stocks Open Flat as Pharma Shares Lead Gains; Innovent Rises Nearly 2%

Stock News09:53

Hong Kong's benchmark index opened at a standstill on September 21, holding at 24,748.45 points. The Hang Seng Tech Index edged down 0.08% to 4,401.82 points, while the Hang Seng China Enterprises Index inched up 0.05% to 8,229.46 points.

Among Hang Seng Index constituents, INNOVENT BIO (01801) led the advance with a 1.97% gain, followed by CSPC PHARMA (01093) rising 1.51% and TENCENT (00700) climbing 1.34%. On the downside, TRIP.COM-S (09961) slipped 1.57%, marking the steepest decline among index members.

Within the Hang Seng Tech Index, ILUVATAR COREX (09903) gained 1.78%, TENCENT (00700) advanced 1.34%, and BABA-W (09988) rose 1.28% to lead the winners. TRIP.COM-S (09961) again recorded the largest drop, falling 1.57%.

In other market movements, TRANSWARP (06727) began trading on the Main Board of the Hong Kong Stock Exchange today, opening at HK$49—unchanged from its offer price—before dipping below that level shortly after the market opened.

Sector performance showed pharmaceutical stocks broadly strengthening, while memory and semiconductor shares were active at the open. Gold-related equities eased slightly, Chinese brokerage stocks mostly declined, and internet technology names were mixed.

On the macro front, U.S. stock benchmarks finished Friday's session with mixed results, though memory chip stocks posted solid gains. Hong Kong stocks closed the previous week higher, with the Hang Seng Index settling at 24,750.78 points, up 0.60%, and the Hang Seng Tech Index advancing 2.20% to close at 4,405.50 points.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment